1. Home
  2. BWAY vs BSL Comparison

BWAY vs BSL Comparison

Compare BWAY & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • BSL
  • Stock Information
  • Founded
  • BWAY 2003
  • BSL 2010
  • Country
  • BWAY Israel
  • BSL United States
  • Employees
  • BWAY N/A
  • BSL N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • BSL Trusts Except Educational Religious and Charitable
  • Sector
  • BWAY Health Care
  • BSL Finance
  • Exchange
  • BWAY Nasdaq
  • BSL Nasdaq
  • Market Cap
  • BWAY 159.3M
  • BSL 183.2M
  • IPO Year
  • BWAY 2019
  • BSL N/A
  • Fundamental
  • Price
  • BWAY $10.00
  • BSL $14.58
  • Analyst Decision
  • BWAY Strong Buy
  • BSL
  • Analyst Count
  • BWAY 3
  • BSL 0
  • Target Price
  • BWAY $13.17
  • BSL N/A
  • AVG Volume (30 Days)
  • BWAY 88.8K
  • BSL 71.9K
  • Earning Date
  • BWAY 11-12-2024
  • BSL 01-01-0001
  • Dividend Yield
  • BWAY N/A
  • BSL 9.55%
  • EPS Growth
  • BWAY N/A
  • BSL N/A
  • EPS
  • BWAY 0.04
  • BSL N/A
  • Revenue
  • BWAY $38,631,000.00
  • BSL N/A
  • Revenue This Year
  • BWAY $378.91
  • BSL N/A
  • Revenue Next Year
  • BWAY $20.27
  • BSL N/A
  • P/E Ratio
  • BWAY $122.14
  • BSL N/A
  • Revenue Growth
  • BWAY 34.19
  • BSL N/A
  • 52 Week Low
  • BWAY $4.61
  • BSL $12.19
  • 52 Week High
  • BWAY $10.98
  • BSL $14.56
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 53.76
  • BSL 62.96
  • Support Level
  • BWAY $8.96
  • BSL $14.41
  • Resistance Level
  • BWAY $10.27
  • BSL $14.60
  • Average True Range (ATR)
  • BWAY 0.62
  • BSL 0.15
  • MACD
  • BWAY -0.06
  • BSL 0.03
  • Stochastic Oscillator
  • BWAY 57.76
  • BSL 95.92

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About BSL Blackstone Senior Floating Rate 2027 Term Fund of Beneficial Interest

Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage, which may increase the risk to the Fund.

Share on Social Networks: